Table 1.
Symptoms at time of presentation in Canadian children and adolescents with new-onset inflammatory bowel disease [IBD]. Comparisons are made between children determined to have Crohn’s disease and those with ulcerative colitis or IBD-unclassified.
| Percentage of patients with symptom present at time of diagnosis | Crohn’s disease [n = 698] | Ulcerative colitis/inflammatory bowel disease unclassified [n = 394] | p-value |
|---|---|---|---|
| Abdominal pain | 88% [a major symptom in 51%] | 81% [a major symptom in 32%] | 0.17 |
| 0.002 | |||
| Non-bloody diarrhoea | 30% | 5% | <0.001 |
| Bloody diarrhoea | 40% [a major symptom in 18%] | 87% [a major symptom in 60%] | <0.001 |
| <0.001 | |||
| Linear growth impairment | 22% | 3% | <0.001 |
| Any weight loss | 71% | 62% | 0.004 |
| Perianal lesion[s] [skin tags/fissures/fistula[s]/ abscess[es] | 27% | 2% | <0.001 |
| Extra-intestinal manifestation[s] [joint inflammation/skin lesions] | 15% | 1.2% | <0.001 |
| Oral ulcers | 29% | 9% | <0.001 |
| Fevers | 28% | 11% | <0.001 |